Diabetes is life long affliction that causes a person’s blood sugar level to become too high. With the two main types of diabetes, type 2 is far more common. Around 90% of all adults with diabetes have type 2.
Types
Type 2 is where the body is not creating enough insulin or the body is not reacting correctly to the insulin. This type usually requires the managing of medication, finding the right medication for each person can take time. Also many of the medications have side affects.
Type 1 is when the level of glucose in blood to be too high. This happens when the body isn’t producing enough of the hormone insulin which controls the levels of glucose in blood.
Both types are manageable with the correct advice and medication.
There are articles below that explore the condition in many different ways. Covering new research and evidence.
University of Bristol researchers have discovered a VEGF-C gene therapy that protects the kidneys and may prevent serious complications in people with type 1 diabetes.
A new study supported by the World Health Organisation found that higher dietary fibre intake is associated with a reduced risk of several chronic diseases.
PHE launches new Change4Life campaign to help families cut back on sugar after research reveals children have already exceeded the maximum sugar intake for an 18-year-old by the age of 10.
Professor Iain Chapple from the University of Birmingham UK, explains the link between periodontitis and non-communicable diseases such as Type 2 diabetes
Professor John Wilding from the University of Liverpool discusses how more effective use of treatments and greater support for healthcare professionals can make the difference in the battle against Type 2 diabetes
Chanelle Corena, Type 2 Prevention Lead at Diabetes UK, highlights the 12.3 million people in the UK who are at an increased risk of developing Type 2 diabetes and precisely why prevention and a change in behaviour is crucial in this vein
There are nearly 7,000 children and young adults under 25 currently being treated for type 2 diabetes in England and Wales - about 10 times the number reported before, according to Diabetes UK
When it comes to the field of diabetic retinopathy research, Dr Lalit Pukhrambam at Wayne State University is exploring ways to prevent blinding eye diseases due to diabetes by targeting a protein called thioredoxin-interacting protein (TXNIP). Gene therapy is, therefore, a promising option
Matthew Capehorn, medical director at LighterLife, goes into detail about the common symptoms of diabetes that you might not know about, on World Diabetes Day
Diabetes is described as the epidemic of the 21st Century, in the view of Roche Diabetes Care, who are using digital technology and data management to help patients, healthcare professionals and payers address this costly challenge
Employees are wrongly assuming that keeping active during leisure time will protect them from the danger of sitting for long periods when working in an office, a new study has found
Diabetes UK urges everyone with diabetes - including those who are pregnant - to take up the offer of a free a flu jab to avoid life-threatening diabetes complications winter illnesses can lead to
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group provides a market perspective on the diabetes monitoring and drug delivery innovation fields and explains why these are a scenario for big technology synergy
